These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 7916408)

  • 1. Why does stage 4s neuroblastoma regress spontaneously?
    Pritchard J; Hickman JA
    Lancet; 1994 Sep; 344(8926):869-70. PubMed ID: 7916408
    [No Abstract]   [Full Text] [Related]  

  • 2. Distinct transcriptional MYCN/c-MYC activities are associated with spontaneous regression or malignant progression in neuroblastomas.
    Westermann F; Muth D; Benner A; Bauer T; Henrich KO; Oberthuer A; Brors B; Beissbarth T; Vandesompele J; Pattyn F; Hero B; König R; Fischer M; Schwab M
    Genome Biol; 2008 Oct; 9(10):R150. PubMed ID: 18851746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Congenital stage 1 neuroblastoma evolved into stage 4s.
    Schiavetti A; Foco M; Ingrosso A; Chiriacò D; Ballesio L
    J Pediatr Hematol Oncol; 2009 Jan; 31(1):59-60. PubMed ID: 19125091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of the apoptosis-suppressing protein bcl-2, in neuroblastoma is associated with unfavorable histology and N-myc amplification.
    Castle VP; Heidelberger KP; Bromberg J; Ou X; Dole M; Nuñez G
    Am J Pathol; 1993 Dec; 143(6):1543-50. PubMed ID: 8256847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Receptor tyrosine kinase KIT may regulate expression of genes involved in spontaneous regression of neuroblastoma].
    Lebedev TD; Spirin PV; Suntsova MV; Ivanova AV; Buzdin AA; Prokofjeva MM; Rubtsov PM; Prassolov VS
    Mol Biol (Mosk); 2015; 49(6):1052-5. PubMed ID: 26710790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular basis of spontaneous regression of neuroblastoma: role of neurotrophic signals and genetic abnormalities.
    Nakagawara A
    Hum Cell; 1998 Sep; 11(3):115-24. PubMed ID: 10086274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteomics-based identification of spontaneous regression-associated proteins in neuroblastoma.
    Yu F; Zhu X; Feng C; Wang T; Hong Q; Liu Z; Tang S
    J Pediatr Surg; 2011 Oct; 46(10):1948-55. PubMed ID: 22008333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inverse relationship between trk expression and N-myc amplification in human neuroblastomas.
    Nakagawara A; Arima M; Azar CG; Scavarda NJ; Brodeur GM
    Cancer Res; 1992 Mar; 52(5):1364-8. PubMed ID: 1737399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of N-myc gene amplification in bone marrow specimen of stage IV neuroblastoma patients.
    Brack T; Scholz RB; Milde-Langosch K; Heinsohn S; Löning T; Kabisch H
    Cancer Detect Prev; 1992; 16(3):185-92. PubMed ID: 1458508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spontaneous regression of metastases including meningeal metastasis after gross resection of primary tumor in an infant with stage 4 neuroblastoma.
    Nishio N; Mimaya J; Horikoshi Y; Okada N; Nara T; Takashima Y; Urushihara N; Hasegawa S; Aoki K; Hamasaki M
    J Pediatr Hematol Oncol; 2006 Aug; 28(8):537-9. PubMed ID: 16912596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered expression of cell cycle genes distinguishes aggressive neuroblastoma.
    Krasnoselsky AL; Whiteford CC; Wei JS; Bilke S; Westermann F; Chen QR; Khan J
    Oncogene; 2005 Feb; 24(9):1533-41. PubMed ID: 15592497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroblastoma and the clinical significance of N-myc oncogene amplification.
    Phillips WS; Stafford PW; Duvol-Arnold B; Ghosh BC
    Surg Gynecol Obstet; 1991 Jan; 172(1):73-80. PubMed ID: 1985349
    [No Abstract]   [Full Text] [Related]  

  • 13. Inhibition of N-myc expression and induction of apoptosis by iron chelation in human neuroblastoma cells.
    Fan L; Iyer J; Zhu S; Frick KK; Wada RK; Eskenazi AE; Berg PE; Ikegaki N; Kennett RH; Frantz CN
    Cancer Res; 2001 Feb; 61(3):1073-9. PubMed ID: 11221835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MYCN oncogene amplification in neuroblastoma is associated with worse prognosis, except in stage 4s: the Italian experience with 295 children.
    Tonini GP; Boni L; Pession A; Rogers D; Iolascon A; Basso G; Cordero di Montezemolo L; Casale F; Pession A; Perri P; Mazzocco K; Scaruffi P; Lo Cunsolo C; Marchese N; Milanaccio C; Conte M; Bruzzi P; De Bernardi B
    J Clin Oncol; 1997 Jan; 15(1):85-93. PubMed ID: 8996128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroblastoma 4S: a heterogeneous disease with variable risk factors and treatment strategies.
    van Noesel MM; Hählen K; Hakvoort-Cammel FG; Egeler RM
    Cancer; 1997 Sep; 80(5):834-43. PubMed ID: 9307181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased expression of the proto-oncogene, c-myc, in human neuroblastoma cells by reversible inhibition of cell growth.
    Fukuchi K; Tomoyasu S; Watanabe K; Suzuki H; Kaetsu T; Takagi Y; Tsuruoka N; Gomi K
    Anticancer Res; 1991; 11(6):1967-73. PubMed ID: 1776829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroblastoma in the first year of life: clinical and biologic factors influencing outcome.
    Grosfeld JL; Rescorla FJ; West KW; Goldman J
    Semin Pediatr Surg; 1993 Feb; 2(1):37-46. PubMed ID: 8062021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased Ras expression and caspase-independent neuroblastoma cell death: possible mechanism of spontaneous neuroblastoma regression.
    Kitanaka C; Kato K; Ijiri R; Sakurada K; Tomiyama A; Noguchi K; Nagashima Y; Nakagawara A; Momoi T; Toyoda Y; Kigasawa H; Nishi T; Shirouzu M; Yokoyama S; Tanaka Y; Kuchino Y
    J Natl Cancer Inst; 2002 Mar; 94(5):358-68. PubMed ID: 11880474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression profiling of favorable and unfavorable neuroblastomas.
    Hiyama E; Hiyama K; Yamaoka H; Sueda T; Reynolds CP; Yokoyama T
    Pediatr Surg Int; 2004 Jan; 20(1):33-8. PubMed ID: 14691637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival from locally invasive or widespread neuroblastoma without cytotoxic therapy.
    Kushner BH; Cheung NK; LaQuaglia MP; Ambros PF; Ambros IM; Bonilla MA; Gerald WL; Ladanyi M; Gilbert F; Rosenfield NS; Yeh SD
    J Clin Oncol; 1996 Feb; 14(2):373-81. PubMed ID: 8636746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.